Oral solid dosage form,Oral solid dosage form

2 trials

Sponsors

Duopharma Biotech Berhad

Conditions

Healthy subjects Bioequivalence ApixabanHealthy subjects bioequivalence study generic Simvastatin/ Ezetimibe 20/10 mg Tablet

Phase 1

Bioequivalence Study of Generic Simvastatin/ Ezetimibe 20/10 mg Tablet

Active, not recruitingTCTR20230620003

Duopharma Biotech BerhadHealthy subjects bioequivalence study generic Simvastatin/ Ezetimibe 20/10 mg Tablet

Start: 2021-04-07Target: 60Updated: 2026-08-03

Bioequivalence Study of Generic Apixaban Tablet 5 mg

Active, not recruitingTCTR20230621009

Duopharma Biotech BerhadHealthy subjects Bioequivalence Apixaban

Start: 2022-01-03Target: 26Updated: 2026-08-03